The Role Of N-linked Protein Glycosylation In Campylobacter Jejuni Pathogenesis
Funder
National Health and Medical Research Council
Funding Amount
$757,600.00
Summary
Protein glycosylation is crucial in enabling C. jejuni to colonize poultry, which is the most common route to human infection. The roles played by this modification remain almost completely unknown yet are likely to be multi-factorial. This project will determine the function of glycosylation and thus lead to eventual interventions aimed at reducing the organism in poultry for human consumption.
Uncovering Novel Roles Of Escherichia Coli Flagella And LPS In Uropathogenesis
Funder
National Health and Medical Research Council
Funding Amount
$404,677.00
Summary
Urinary tract infections (UTI) are common infectious diseases in humans. Uropathogenic Escherichia coli (UPEC) cause most UTI. UPEC produce factors that promote their survival and influence disease such as flagella. We have identified anti-inflammatory responses as a key element of UTI and have shown that these responses contribute to control of UTI. In this project, we will investigate how the UPEC flagella component, FliC, contributes to anti-inflammatory responses and what this means for UTI.
Understanding The Impact Of Epigenetic Gene Regulation On Helicobacter Pylori Persistence And Pathogenesis.
Funder
National Health and Medical Research Council
Funding Amount
$757,896.00
Summary
Helicobacter pylori is a highly persistent pathogen and remains a significant problem worldwide, causing gastritis, peptic ulcer disease and gastric cancer. This project will increase our understanding of how H. pylori infection persists for the life of its human host and will provide knowledge that is critical in developing new strategies for preventing these infections.
Mechanisms Of Disease Caused By Hospital-acquired Pathogens
Funder
National Health and Medical Research Council
Funding Amount
$465,218.00
Summary
We are currently experiencing unprecedented levels of antibiotic resistance in human pathogens. Unfortunately, the drug development pipeline is drying up, with almost no novel therapeutic options expected in the near future. This proposal aims to identify the mechanisms by which the most important antibiotic-resistant human pathogens make us sick. The expected outcomes are the identification of new targets that may be amenable to future drug development. These targets are aimed at making the org ....We are currently experiencing unprecedented levels of antibiotic resistance in human pathogens. Unfortunately, the drug development pipeline is drying up, with almost no novel therapeutic options expected in the near future. This proposal aims to identify the mechanisms by which the most important antibiotic-resistant human pathogens make us sick. The expected outcomes are the identification of new targets that may be amenable to future drug development. These targets are aimed at making the organisms less capable of causing disease in humans.Read moreRead less
Death Receptor Signaling During E. Coli And Salmonella Infection
Funder
National Health and Medical Research Council
Funding Amount
$586,076.00
Summary
Upon encountering invading microorganisms, the body’s immune system usually initiates an inflammatory response to recruit populations of immune cells to the site of infection. To counter this attack, many bacterial pathogens have evolved distinct ways of disarming the inflammatory response. We are investigating the discovery that gastrointestinal bacteria such as Salmonella and pathogenic E. coli specifically interfere with the messages sent by the body’s innate sensors to recruit killer immune ....Upon encountering invading microorganisms, the body’s immune system usually initiates an inflammatory response to recruit populations of immune cells to the site of infection. To counter this attack, many bacterial pathogens have evolved distinct ways of disarming the inflammatory response. We are investigating the discovery that gastrointestinal bacteria such as Salmonella and pathogenic E. coli specifically interfere with the messages sent by the body’s innate sensors to recruit killer immune cells.Read moreRead less
Targeting Glycointeractions To Generate New Opportunities To Treat And Prevent Bacterial Infections.
Funder
National Health and Medical Research Council
Funding Amount
$774,540.00
Summary
Bacteria and bacterial toxins can interact with complex sugar structures on human cells called glycans. My research team has identified new and important glycan interactions used by bacteria that cause diseases ranging from pneumonia, meningitis and food borne infections to urinary tract and sexually transmitted diseases. Now that these interactions have been discovered, they can be exploited to create drugs and vaccines that may treat and prevent disease by blocking the glycan interactions.
Using Genetic Tools To Study Helicobacter Pylori Pathogenesis And Persistence
Funder
National Health and Medical Research Council
Funding Amount
$316,449.00
Summary
H. pylori infection is the leading cause of gastric ulcer disease and stomach cancer. In light of emerging antibiotic resistance and failed vaccine trials, alternative therapies are needed to treat this lifelong infection. This project aims to develop tools to identify and characterize genes required by H. pylori for infection which will serve as new drug targets. This new knowledge will also contribute to a better understanding of the persistence of this and other bacteria.
Infectious diseases plague mankind; with infections responsible for approximately 20% of all deaths worldwide. New strategies are urgently needed and we have positioned our research to address questions around how to forestall bacterial pathogens in the initial phases of invasion of human tissues and provide full understanding of the key molecules on the surfaces of bacterial cells. This fundamental knowledge is crucial to new drugs, vaccines and infection-resistant medical devices.